Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Alzheimer'S Disease : JAD|February 13, 2021
DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling PathwaysLi Yuan, Jun Zhang, Jun-Hong Guo, et al.The Journal of Clinical Investigation|April 6, 2012
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomersTheresa R Bomfim, Leticia Forny-Germano, Luciana B Sathler, et al.The Journal of Pathology|February 14, 2018
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's diseaseAndre F Batista, Leticia Forny-Germano, Julia R Clarke, et al.Cell Metabolism|December 10, 2013
TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeysMychael V Lourenco, Julia R Clarke, Rudimar L Frozza, et al.Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.Pageof 3